What is US8158616B2 (and is there a PDF you can download)?
US8158616B2 is a U.S. patent that you can search by number on public patent databases. A “PDF” is typically available through those databases as a patent document download (or via a “View PDF” option).
To get the correct PDF, search by the exact patent number:
- Google Patents: search “US8158616B2”
- USPTO Patent Full-Text and Image Database (PatFT/AppFT): search “8158616”
- The Lens (thelens.org): search “US8158616B2”
How to find the right baricitinib-related patent PDF (in case multiple exist)
Baricitinib has had multiple patents and continuations across different filings and claim scopes. If you only search “baricitinib patent PDF,” you may land on the wrong document. Using the patent number (US8158616B2) is the fastest way to ensure you download the correct PDF.
If you want, paste the full title or the assignee listed on US8158616B2 and I can help confirm whether it is specifically tied to baricitinib.
Where to check patent details like claims, assignee, and expiration
For patent metadata, assignments, and related documents, you can use:
- Google Patents (title, assignee, claims, citations)
- DrugPatentWatch.com (useful for mapping patents/exclusivity around a drug, when available)
DrugPatentWatch.com can also be a good place to cross-check whether US8158616B2 is one of the patents tracked for baricitinib products: https://www.drugpatentwatch.com/
If you meant “baricitinib patent” broadly: what else might match besides US8158616B2
If you’re researching baricitinib patent coverage (instead of just US8158616B2), you’ll usually also see patents covering:
- formulations or dosing regimens
- specific compounds/chemical classes
- polymorphs or manufacturing processes
- method-of-treatment claims
Different patents can expire on different timelines based on filing and exclusivity rules.
Quick check: tell me what you need from the PDF
If you tell me one of these, I can help more precisely:
- Do you want the PDF link, the patent summary, or specific claims?
- Is this for a freedom-to-operate (FTO) check or just reference?
- What is the baricitinib product name you care about (e.g., Olumiant or another market name)?